GPER1 and neoplasm: The in vitro experiment demonstrated that targeting GPER in SKBR3 cell lines endogenously expressing GPER kept tumor cells arrested in the G2/M cell cycle (81), wherein dormant tumors were susceptible to a cytotoxicity effect.